Therapeutic Outcomes and Prognostic Factors in Childhood Absence Epilepsy.
10.3988/jcn.2016.12.2.160
- Author:
Hye Ryun KIM
1
;
Gun Ha KIM
;
So Hee EUN
;
Baik Lin EUN
;
Jung Hye BYEON
Author Information
1. Department of Pediatrics, College of Medicine, Korea University, Seoul, Korea. byeonagnes@naver.com
- Publication Type:Original Article
- Keywords:
epilepsy;
absence seizures;
prognostic factors;
valproic acid;
lamotrigine
- MeSH:
Academic Medical Centers;
Child;
Electroencephalography;
Epilepsy;
Epilepsy, Absence*;
Ethosuximide;
Follow-Up Studies;
Freedom;
Humans;
Korea;
Prognosis;
Retrospective Studies;
Seizures;
Treatment Failure;
Valproic Acid
- From:Journal of Clinical Neurology
2016;12(2):160-165
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND AND PURPOSE: Childhood absence epilepsy (CAE) is one of the most common types of pediatric epilepsy. It is generally treated with ethosuximide (ESM), valproic acid (VPA), or lamotrigine (LTG), but the efficacy and adverse effects of these drugs remain controversial. This study compared initial therapy treatment outcomes, including VPA-LTG combination, and assessed clinical factors that may predict treatment response and prognosis. METHODS: Sixty-seven patients with typical CAE were retrospectively enrolled at the Korea University Medical Center. We reviewed patients' clinical characteristics, including age of seizure onset, seizure-free interval, duration of seizure-free period, freedom from treatment failure, breakthrough seizures frequency, and electroencephalogram (EEG) findings. RESULTS: The age at seizure onset was 7.9±2.7 years (mean±SD), and follow-up duration was 4.4±3.7 years. Initially, 22 children were treated with ESM (32.8%), 23 with VPA (34.3%), 14 with LTG (20.9%), and 8 with VPA-LTG combination (11.9%). After 48 months of therapy, the rate of freedom from treatment failure was significantly higher for the VPA-LTG combination therapy than in the three monotherapy groups (p=0.012). The treatment dose administrated in the VPA-LTG combination group was less than that in the VPA and LTG monotherapy groups. The shorter interval to loss of 3-Hz spike-and-wave complexes and the presence of occipital intermittent rhythmic delta activity on EEG were significant factors predicting good treatment response. CONCLUSIONS: This study showed that low-dose VPA-LTG combination therapy has a good efficacy and fewer side effects than other treatments, and it should thus be considered as a firstline therapy in absence epilepsy.
